Comparability of critical quality attributes for establishing biosimilarity.
about
Analytical Similarity Assessment in Biosimilar Studies.Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab.Testing drug additivity based on monotherapies.A Calibrated Power Prior Approach to Borrow Information from Historical Data with Application to Biosimilar Clinical Trials.Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.
P2860
Comparability of critical quality attributes for establishing biosimilarity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Comparability of critical quality attributes for establishing biosimilarity.
@en
Comparability of critical quality attributes for establishing biosimilarity.
@nl
type
label
Comparability of critical quality attributes for establishing biosimilarity.
@en
Comparability of critical quality attributes for establishing biosimilarity.
@nl
prefLabel
Comparability of critical quality attributes for establishing biosimilarity.
@en
Comparability of critical quality attributes for establishing biosimilarity.
@nl
P2860
P356
P1476
Comparability of critical quality attributes for establishing biosimilarity.
@en
P2093
Jason J Z Liao
Patrick F Darken
P2860
P304
P356
10.1002/SIM.5564
P407
P577
2012-08-17T00:00:00Z